Victrex (GB:VCT) has released an update.
Victrex PLC reported a 20% year-on-year volume growth in Q3, maintaining its full-year volume guidance amidst a challenging environment, particularly in the Medical sector due to ongoing customer destocking. The company’s revenue saw a slight increase, with a robust balance sheet and lower expected capital expenditure for the rest of the year. Despite the headwinds, Victrex expressed confidence in its medium to long-term prospects, driven by improvements in various end-markets and a focus on cost discipline.
For further insights into GB:VCT stock, check out TipRanks’ Stock Analysis page.
